Malignant transformation of thyroid follicular cells by galectin-3

Cancer Letters

Volumn 195, Issue 1, 2003, Pages 111-119

  Takenaka, Yukinori ^a   Inohara, Hidenori ^a   Yoshii, Tadashi ^a   Oshima, Kazuo ^a   Nakahara, Susumu ^a   Akahani, Shiro ^a   Honjo, Yuichiro ^a   Yamamoto, Yoshifumi ^a   Raz, Avraham ^b   Kubo, Takeshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Galectin 3; Thyroid; Transformation

Indexed keywords

AGAR; CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; GALECTIN 3; REPLICATION FACTOR C;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL LINE; CELL TRANSFORMATION; CLONOGENESIS; CONTACT INHIBITION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA; THYROID FOLLICLE CELL;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0038735623     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00056-9     Document Type: Article

References (28)

1. Barondes S.H., Cooper D.N., Gitt M.A., Leffler H. Galectins: structure and function of a large family of animal lectins. J. Biol. Chem. 269:1994;20807-20810.
2. Herrmann J., Turck C.W., Atchison R.E., Huflej M.E., Poulter L., Gitt M.A., Burlingame A.L., Barondes S.H., Leffler H. Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline-, glycine-, tyrosine-rich sequence with bacterial and tissue collagenase. J. Biol. Chem. 268:1993;26704-26711.
3. Inohara H., Raz A. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res. 55:1995;3267-3271.
4. Inohara H., Akahani S., Koths K., Raz A. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res. 56:1996;4530-4534.
5. Dagher S.F., Wang J.L., Patterson R.J. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. Natl. Acad. Sci. USA. 92:1995;1213-1217.
6. Akahani S., Nangia-Makker P., Inohara H., Kim H.R., Raz A. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57:1997;5272-5276.
7. Inohara H., Honjo Y., Yoshii T., Akahani S., Yoshida J., Hattori K., Okamoto S., Sawada T., Raz A., Kubo T. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer. 85:1999;2475-2484.
8. Schoeppner H.L., Raz A., Ho S.B., Bresalier R.S. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer. 75:1995;2818-2826.
9. Hsu D.K., Dowling C.A., Jeng K.C., Chen J.T., Yang R.Y., Liu F.T. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer. 81:1999;519-526.
10. Honjo Y., Inohara H., Akahani S., Yoshii T., Takenaka Y., Yoshida J., Hattori K., Tomiyama Y., Raz A., Kubo T. Expression of galectin-3 as a prognostic marker in tongue carcinoma. Clin. Cancer Res. 6:2000;4635-4640.
11. Burch H.B., Burman K.D., Reed H.L., Buckner L., Raber T., Ownbey J.L. Fine needle aspiration of thyroid nodules: determinants of insufficiency rate and malignancy yield at thyroidectomy. Acta Cytol. 40:1996;1176-1183.
12. Franssila K.O., Ackerman L.V., Brown C.J.L., Hedlinger C.E. Follicular carcinoma. Semin. Diagn. Pathol. 2:1985;101-122.
13. Xu X.C., el-Naggar A.K., Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors; potential diagnostic implications. Am. J. Pathol. 147:1995;815-822.
14. Bartolazzi A., Gasbarri A., Papotti M., Bussolati G., Lucante T., Khan A., Inohara H., Marandino F., Orlandi F., Nardi F., Vecchione A., Tecce R., Larsson O. Thyroid Cancer Study Group, application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 357:2001;1644-1650.
15. Yoshii T., Inohara H., Takenaka Y., Honjo Y., Akahani S., Nomura T., Raz A., Kubo T. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int. J. Oncol. 18:2001;787-792.
16. Martin A., Huber G., Davies T. Induction of human thyroid cell ICAM-1 (CD54) antigen expression and ICAM-1-mediated lymphocyte binding. Endocrinology. 127:1990;651-657.
17. Oliver M.H., Harrison N.K., Bishop J.E., Cole P.J., Laurent G.J. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 92:1989;513-518.
18. Sato S., Hughes R.C. Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin. J. Biol. Chem. 267:1992;6983-6990.
19. Bresalier R.S., Mazurek N., Sternberg L.R., Byrd J.C., Yunker C.K., Nangia-Makker P., Raz A. Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin-3. Gastroenterology. 115:1998;287-296.
20. Yang R.Y., Hsu D.K., Liu F.T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;6737-6742.
21. Moon B.K., Lee Y.J., Battle P., Jessup J.M., Raz A., Kim H.R.C. Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am. J. Pathol. 159:2001;1055-1060.
22. Matarrese P., Tinari N., Semeraro M.L., Natoli C., Iacobelli S., Malorni W. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett. 473:2000;311-315.
23. Kim H.R., Lin H.M., Biliran H., Raz A. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res. 59:1999;4148-4154.
24. Raffo A.J., Perlman H., Chen M.W., Day M.L., Streitman J.S., Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55:1995;4438-4445.
25. Yu F., Finley R.L., Raz A., Kim H.R.C. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria: a role for synexin in galectin-3 translocation. J. Biol. Chem. 277:2002;15819-15827.
26. Yoshii T., Fukumori T., Honjo Y., Inohara H., Kim H.R.C., Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J. Biol. Chem. 277:2002;6852-6857.
27. Aboussekhra A., Biggerstaff M., Shivji M.K., Vilpo J.A., Moncollin V., Podust V.N., Protic M., Hubscher U., Egly J.M., Wood R.D. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell. 80:1995;859-868.
28. Taya Y. RB kinases and RB-binding proteins: new points of view. Trends Biochem. Sci. 22:1997;14-17.